This unexpected difference in the tumor spectrum of Fancj-deficient mice compared with other FA mouse models raised the possibility that FANCJ performs roles that are independent of the canonical FA pathway, at least with respect to preventing lymphoma development. The gene discussed is BRIP1; the disease is lymphoma.